Moderna taps Singapore, Hong Kong for COVID era expansion

Taiwan, Malaysia also picked; CEO Bancel eyes vaccine plants in Asia

Moderna, which developed one of the main COVID-19 vaccines used worldwide, is looking to begin production in Asia. (Source photo by Akira Kodaka and Reuters)

DYLAN LOH, Nikkei staff writer

February 16, 2022 14:19 JST

SINGAPORE -- COVID-19 vaccine maker Moderna will expand into Singapore, Hong Kong, Taiwan and Malaysia this year to better serve the Asian market, where its shots continue to be used to battle the coronavirus pandemic.

The Nasdaq-listed company announced its plan on Wednesday but did not disclose how much it was investing to set up offices in those locations to support the expansion, or how many additional people it will be hiring.